Clinical Trials in Los Angeles

Showing 5621-5640 of 16,901 trials

Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery

NCT01969058

This phase II study was done in HIV-infected participants on antiretroviral therapy to evaluate the effects of isotretinoin (a drug that is approved for use in the treatment of severe acne) on the immune system. The immune system helps the body fight infections. When the immune system is not working well, one may be at greater risk for diseases that are common in aging, like heart disease, weaker bones, and kidney disease.

HIV-1 Infection

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections76 participantsStarted Jul 2014

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +12 more locations

COMPLETEDPhase 3< 1 mile

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

NCT03537508

The purpose of this study was to compare the immunogenicity and describe the safety of MenACYW conjugate vaccine and MENVEO® when both are administered concomitantly with routine pediatric vaccines to healthy infants and toddlers in the US.

Healthy Volunteers (Meningococcal Infection)

Sanofi Pasteur, a Sanofi Company2,627 participantsStarted Apr 2018

Birmingham, Alabama, United States • Dothan, Alabama, United States • Phoenix, Arizona, United States +67 more locations

Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Find Trials by Condition in Los Angeles

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors

Treatment of Interproximal Cavities on Primary Molar Teeth With Silver Diamine Fluoride

Atrasentan in Patients With IgA Nephropathy

First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)

COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA

Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium

MyoVista Measurements in Patients With Atherosclerosis and CAD

A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis

A Study to Evaluate the Effects of Pre-Meal Whey Protein Microgels Administration on Post-Prandial Glycemic Response.

Determinants of the Effectiveness of Robot-assisted Hand Movement Training

A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study

Lay-Delivered Behavioral Activation in Senior Centers

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)